Search Results - "Gürman, G"

Periodontal status and post-transplantation complications following intensive periodontal treatment in patients underwent allogenic hematopoietic stem cell transplantation conditioned with myeloablative regimen by Gürgan, CA, Özcan, M, Karakuş, Ö, Zincircioğlu, G, Arat, M, Soydan, E, Topcuoglu, P, Gürman, G, Bostancı, HS

“…:  Objectives:  Evaluation of the periodontal status is necessary prior to management with high‐dose chemotherapy before hematopoietic stem cell therapy…”
Get full text

PP-344 Ultrasonic Catheter Directed Thrombolysis Experience in the Treatment of Internal Juguler Venous Thrombosis by Gerede, D.M, Tekin, B, Vurgun, K, Özdöl, Ç, Gürman, G, Durdu, S

“…Introduction EKOS (Endowave Infusion Catheter System) is to enhance catheter-directed thrombolysis by accelerating the fibrinolytic process with the…”
Get full text

Turkish Transplant Registry: a comparative analysis of national activity with the EBMT European Activity Survey by Arat, M, Arpaci, F, Ertem, M, Gürman, G

“…SCT is a curative approach using chemo-, radio- and immunotherapy for malignant and non-malignant hematological disorders. The European Group for Blood and…”
Get full text

Mobilization of peripheral blood stem cells with chemotherapy and recombinant human granulocyte colony‐stimulating factor (rhG‐CSF): a randomized evaluation of different doses of rhG‐CSF by Demirer, T., Ayli, M., Ozcan, M., Gunel, N., Haznedar, R., Dagli, M., Fen, T., Genc, Y., Dincer, S., Arslan, O., Gürman, G., Demirer, S., Ozet, G., Uysal, A., Konuk, N., Ilhan, O., Koc, H., Akan, H.

“…To date, no randomized study has compared different doses of recombinant human granulocyte colony‐stimulating factor (rhG‐CSF) following submyeloablative…”
Get full text

Proposal for a surrogate surgical invasiveness score to obtain a ‘post hoc’ quantification of surgical stress and tissue trauma in the context of postoperative outcome assessments by Biro, P., Gurman, G.

Get full text

Autoimmune thrombocytopenia in a patient with small cell lung cancer developing after chemotherapy and resolving following autologous peripheral blood stem cell transplantation by DEMIRER, T, CELEBI, H, KOC, H, ARAT, M, ÜSTÜN, C, DEMIRER, S, DILEK, I, ÖZCAN, M, ILHAN, O, AKAN, H, GÜRMAN, G

“…A 46-year-old white male with small cell lung cancer (SCLC) limited to the thorax developed autoimmune thrombocytopenic purpura (AITP), following a…”
Get full text

Lancet's unethical behavior by Gurman, G M

Get full text

Hepatitis B virus infection in allogeneic bone marrow transplantation by ÜSTÜN, C, KOC, H, UYSAL, A, BEKSAC, M, KARAYALCIN, S, AKYOL, G, GÜRMAN, G, ILHAN, O, AKAN, H, ÖZCAN, M, ARSLAN, Ö, KONUK, N

“…Fourty-four patients who underwent allogeneic bone marrow transplantation (alloBMT) were studied for hepatitis B virus (HBV)-related complications. The mean…”
Get full text

Effects of ABO incompatibility in allogeneic hematopoietic stem cell transplantation by Ataca Atilla, P., Akkus, E., Atilla, E., Gokmen, N., Civriz Bozdag, S., Kocak Toprak, S., Kurt Yuksel, M., Ozcan, M., Demirer, T., Ilhan, O., Beksac, M., Akan, H., Arslan, O., Topcuoglu, P., Gurman, G.

“…The impact of ABO mismatch on outcomes following allo-HSCT remains controversial. In this study, our aim is to define the effect of ABO mismatch on…”
Get full text

P19 EXTERNAL VALIDATION OF THREE EXISTING EARLY MYELOMA RELAPSE SCORES (BY EBMT, CIBMTR, AND GIMEMA) IN A SINGLE CENTER SHOWS MAJOR DIFFERENCES by Beksac, M, Cengiz Seval, G, Civriz Bozdag, S, Toprak, SK, Kurt Yuksel, M, Topcuoglu, P, Arslan, O, Ozcan, M, Demirer, T, Ilhan, O, Gurman, G

Get full text

Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party by Koenecke, C, Heim, D, van Biezen, A, Heuser, M, Aljurf, M, Kyrcz-Krzemien, S, Volin, L, de Souza, C A, Gedde-Dahl, T, Sengeloev, H, Schanz, U, Komarnicki, M, Arroyo, C H, Tholouli, E, Gluckman, E, Esquirol, A, Yakoub-Agha, I, Gürman, G, Olavarria, E, Kröger, N

Get full text

AGE IS NOT IMPORTANT IN FIT ELDERLY PATIENTS WITH AGGRESSIVE LYMPHOMA by Ilhan, O., Uslu, A., Cengiz Seval, G., Tap, E., Basarir, U., Civriz Bozdag, S., Toprak, S., Kurt Yuksel, M., Topcuoglu, P., Arslan, O., Ozcan, M., Demirer, T., Akan, H., Gurman, G.

Get full text

Extracorporeal photochemotherapy in mycosis fungoides by Atilla, E., Atilla, P.A., Bozdag, S.C., Yuksel, M.K., Toprak, S.K., Topcuoglu, P., Akay, B.N., Sanli, H., Akan, H., Demirer, T., Beksac, M., Arslan, O., Ozcan, M., Gurman, G., Ilhan, O.

“…Extracorporeal photo-chemotherapy (ECP, photopheresis) is an approved treatment modality for mycosis fungoides (MF). Our aim is to present our ECP data for MF…”
Get full text

Donor Leukocyte Infusions for the Treatment of Leukemia Relapse After Allogeneic Hematopoietic Cell Transplantation with Myeloablative Conditioning by Gürman, G

“…Leukemic relapse after allogeneic transplantation is a difficult problem. Conventional treatment modalities or second transplants have not provided the…”
Get full text

Acoustic Monitoring of Lung Sounds for the Detection of One-Lung Intubation by Tejman-Yarden, S, Zlotnik, A, Weizman, L, Tabrikian, J, Cohen, A, Weksler, N, Gurman, G M.

“…Monitoring methods for the early diagnosis of one-lung intubation (OLI) are nonspecific and controversial. In this study, we evaluated a new acoustic…”
Get full text

A prospective registration study to determine feasibility of hematopoietic SCT in adults with acute leukemia: planning, expectations and reality by Labopin, M, Gorin, N-C, Polge, E, Socié, G, Gurman, G, Gluckman, E, Jindra, P, Poiré, X, Schäfer-Eckart, K, Ruutu, T, Milone, G, Arcese, W, Mohty, M, Rocha, V

“…For adults with acute leukemia, it is important to know whether the therapeutic schemes initially planned were actually implemented. The European Group for…”
Get full text

Imatinib monitoring in chronic myeloid leukemia patients by Kılıç, P., Kayaaltı, Z., Gündüz, M., Gürman, G., Söylemezoğlu, T.

Get full text

DONOR LYMPHOCYTE INFUSIONS INDUCE DURABLE RESPONSES IN PATIENTS WITH FOLLICULAR, MANTLE AND T CELL LYMPHOMAS RELAPSING AFTER AN ALLOSCT. AN EBMT‐LWP STUDY by Robinson, S., Boumendil, A., Finel, H., Khvedelidze, I., Kanfer, E., Peggs, K., Fuesrt, S., Ram, R., Marjit, E., Vandenberghe, E., Afanasyev, B., Wulf, G., Maertens, J., Tsolukani, A., Schapp, N., Beelen, D., Chalandon, Y., Gurman, G., Finke, J., Bron, D., Tischer, J., Corradini, P., Caballero, D., Potter, V., Kroger, N., Burney, C., Schmitz, N., Sureda, A., Dreger, P., Montoto, S.

Get full text

Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies by Gürman, G., Arat, M., Ilhan, O., Konuk, N., Beksaç, M., Çelebi, H., Özcan, M., Arslan, Ö., Üstün, C., Akan, H., Uysal, A., Koç, H.

“…The effect of allogeneic hematopoietic cell transplantation (alloHCT) on hematologic malignancies is based on the graft-versus-malignancy effect. Obtaining…”
Get full text

Donor leukocyte infusion for relapsed ANLL after allogeneic BMT and the use of interferon alpha to induce graft-versus-leukemia effect by Gürman, G, Arslan, O, Koç, H, Akan, H

Get more information